This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Scholl, P. F. Articles by Groopman, J. D. Search for Related Content PubMed PubMed Citation Articles by Scholl, P. F. Articles by Groopman, J. D.

Long-term Stability of Human Aflatoxin B₁ Albumin Adducts Assessed by Isotope Dilution Mass Spectrometry and High-Performance Liquid Chromatography–Fluorescence

Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland

Requests for reprints: John D. Groopman, Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205-2103. Phone: 410-955-3720; Fax: 410-955-0617. E-mail: jgroopma{at}jhsph.edu

The measurement of the aflatoxin B₁-lysine serum albumin adduct in human blood samples is the most facile biomarker for the assessment of chronic exposure to aflatoxin B₁. Many technologies have been developed for the measurement of this protein adduct including immunoassays, high-performance liquid chromatography (HPLC) with fluorescence detection, and a newly developed isotope-dilution mass spectrometry method. Irrespective of the technology used to determine this adduct level, an important question remains about the long-term stability of this damage product in stored samples. To address this issue, 19 human serum samples that had been previously analyzed for the aflatoxin B₁-lysine adduct by high-performance liquid chromatography–fluorescence in 1989 were re-analyzed by isotope dilution mass spectrometry after storage at –80°C. The adduct concentrations measured by these two techniques were identical within 4% over the range 5 to 100 pg of aflatoxin B₁-lysine/mg albumin. In addition, the specific chemical structure of the aflatoxin B₁-lysine adduct in human samples was confirmed for the first time by collision-induced dissociation full scan mass spectrometry analysis of the protonated adduct molecular ion. These results illustrate that the aflatoxin B₁-lysine serum albumin adduct can be stable in human serum stored at –80°C since 1989, and this provides confidence for the measurement of this biomarker in repository samples from epidemiologic investigations. (Cancer Epidemiol Biomarkers Prev 2008;17(6):1436–9)

This article has been cited by other articles:

				H.-C. Wu, Q. Wang, H.-I Yang, H. Ahsan, W.-Y. Tsai, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella Aflatoxin B1 Exposure, Hepatitis B Virus Infection, and Hepatocellular Carcinoma in Taiwan Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 846 - 853. [Abstract] [Full Text] [PDF]